About Us

Our Leadership

Our leadership team are determined to reshape the UK’s medicines discovery industry.

They specialise in driving scientific innovation, new technologies and encouraging collaboration. They understand the challenges facing medicine discovery and the needs of big pharma, academia, leading technology providers, SMEs, charities and start-ups.

Professor Chris Molloy

Professor Chris Molloy

Chief Executive Officer

BIO  
Dr Nicola Heron

Dr Nicola Heron

Chief Strategic Impact Officer

BIO  
Clare Atherton

Clare Atherton

Chief People Officer

BIO  
Sinead McCormack

Sinead McCormack

Chief Financial Officer

BIO  
Robert Sherville-Payne

Robert Sherville-Payne

General Counsel and Company Secretary

BIO